Cetek

Cetek Corporation was a biotechnology company based in Marlborough, Massachusetts, that specialized in high-throughput screening (HTS) for drug discovery. The company's core technology was a proprietary platform based on capillary electrophoresis (CE), which enabled the rapid screening of complex natural product libraries and synthetic compounds against biological targets. This CE-HTS platform allowed for the identification of active leads with high sensitivity and low reagent consumption. Cetek primarily operated as a technology provider and collaborator for larger pharmaceutical companies seeking to explore natural product chemical diversity. In 2001, the company was acquired by the French drug discovery services firm Cerep to bolster its screening and lead identification capabilities.